NEUROLENS, INC.

Profile

Company Names

NEUROLENS, INC.
EYEBRAIN MEDICAL, INC.

Addresses

1234 LAKESHORE DRIVE #200, COPPELL, TX 75019

3184 AIRWAY AVENUE, SUITE C, COSTA MESA, CA 92626

2227 CLIFF DRIVE, NEWPORT BEACH, CA 92663

540 SAN BERNADINO AVENUE, NEWPORT BEACH, CA 92663

Phone Numbers

888-236-2219
(949) 677-2017

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$126,325,153.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2022-09-01 
$67,642,795.00 
$67,642,795.00 
$0.00 
Equity 
5
2021-11-10 
$14,700,000.00 
$15,000,000.00 
$300,000.00 
Debt 
4
2019-07-24 
$23,819,972.00 
$23,999,998.00 
$180,026.00 
Equity 
3
2017-11-07 
$13,121,905.00 
$14,000,000.00 
$878,095.00 
Equity 
2
2015-12-14 
$6,040,481.00 
$6,040,481.00 
$0.00 
Equity 
1
2014-10-20 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ERIC 
 
BEDNARSKI 
DIRECTOR
PIERRE 
 
BERTRAND 
EXECUTIVE OFFICER
DEAN 
 
BUTLER 
DIRECTOR
DAVIS 
 
CORLEY 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
J. 
ANDY 
CORLEY 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
J. ANDY 
 
CORLEY 
EXECUTIVE OFFICER, DIRECTOR
TOM 
 
FINZI 
DIRECTOR
TOM 
 
FRINZI 
DIRECTOR
STEVE 
T. 
KIRBY 
DIRECTOR
JEFFREY 
 
KRALL 
PROMOTER
DAS 
 
NARAYANDAS 
DIRECTOR
AKHILESH 
 
PATHIPATI 
DIRECTOR
DANIEL 
 
PERALES 
EXECUTIVE OFFICER
DANNY 
 
PERALES 
EXECUTIVE OFFICER
ARIC 
 
PLUMLEY 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-11-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-11-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-24 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-24 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-14 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#